Vicarious Surgical CTO sells over $2,300 in stock By Investing.com

In a recent move, the Chief Technology Officer of Vicarious Surgical Inc. (NYSE:RBOT), Sammy Khalifa, has sold a portion of his holdings in the company. The transaction, which took place on June 3, 2024, involved the sale of 7,167 shares of Class A Common Stock at an average price of $0.3214 per share, totaling over $2,300.

The sale was carried out to cover tax withholding obligations related to the vesting of restricted stock units granted on June 2, 2023. According to a footnote in the filing, the shares were sold at multiple prices ranging from $0.3099 to $0.3399. Khalifa remains a significant shareholder after the sale, with a total of 1,189,209 shares still in his possession.

Investors often monitor insider transactions as they can provide insights into the executives’ perspective on the company’s current valuation and future prospects. While this sale was for tax purposes, it still represents a notable change in Khalifa’s investment in the company.

Vicarious Surgical Inc., known for its innovative approach in the field of orthopedic, prosthetic, and surgical appliances and supplies, has its shares publicly traded under the ticker symbol RBOT. The company, incorporated in Delaware and based in Waltham, Massachusetts, continues to be at the forefront of surgical technology.

For those interested in the detailed figures of the transaction, Khalifa has indicated a willingness to provide full information regarding the number of shares sold at each separate price upon request to either the Securities Exchange Commission, Vicarious Surgical Inc., or any security holder of the company. The transaction was officially filed on June 4, 2024.

InvestingPro Insights

Amidst the insider transaction news at Vicarious Surgical Inc. (NYSE:RBOT), current and prospective investors might be seeking additional context to better understand the company’s financial health and market performance. InvestingPro data and tips offer a deeper dive into the company’s status.

InvestingPro data indicates a challenging financial landscape for RBOT, with a market capitalization of $47.4 million and a negative P/E ratio of -0.83 as of the last twelve months ending in Q1 2024. The company’s operating income also reflects significant losses, reported at -$73.73 million during the same period. Furthermore, the stock’s performance has been volatile, with a 1-year price total return showing a steep decline of -85.24%.

InvestingPro Tips provide additional insights. RBOT holds more cash than debt on its balance sheet, which can be a positive sign of financial stability. However, analysts express concern, as they do not anticipate the company to be profitable this year, and the valuation implies a poor free cash flow yield. Moreover, two analysts have revised their earnings upwards for the upcoming period, suggesting a potential positive outlook amidst the current financial challenges.

For investors intrigued by these insights and seeking to explore further, InvestingPro offers an array of additional tips to inform investment decisions. There are currently 9 additional InvestingPro Tips available for RBOT at Investing.com/pro/RBOT. To access these tips and comprehensive analytics, readers can use coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.